180 related articles for article (PubMed ID: 31133706)
1. Nanoscale reorganization of sarcoplasmic reticulum in pressure-overload cardiac hypertrophy visualized by dSTORM.
Hadipour-Lakmehsari S; Driouchi A; Lee SH; Kuzmanov U; Callaghan NI; Heximer SP; Simmons CA; Yip CM; Gramolini AO
Sci Rep; 2019 May; 9(1):7867. PubMed ID: 31133706
[TBL] [Abstract][Full Text] [Related]
2. Subclinical abnormalities in sarcoplasmic reticulum Ca(2+) release promote eccentric myocardial remodeling and pump failure death in response to pressure overload.
Sedej S; Schmidt A; Denegri M; Walther S; Matovina M; Arnstein G; Gutschi EM; Windhager I; Ljubojević S; Negri S; Heinzel FR; Bisping E; Vos MA; Napolitano C; Priori SG; Kockskämper J; Pieske B
J Am Coll Cardiol; 2014 Apr; 63(15):1569-79. PubMed ID: 24315909
[TBL] [Abstract][Full Text] [Related]
3. Rho-kinase inhibition reverses impaired Ca
Olgar Y; Celen MC; Yamasan BE; Ozturk N; Turan B; Ozdemir S
Cell Calcium; 2017 Nov; 67():81-90. PubMed ID: 29029794
[TBL] [Abstract][Full Text] [Related]
4. Early calcium handling imbalance in pressure overload-induced heart failure with nearly normal left ventricular ejection fraction.
Rouhana S; Farah C; Roy J; Finan A; Rodrigues de Araujo G; Bideaux P; Scheuermann V; Saliba Y; Reboul C; Cazorla O; Aimond F; Richard S; Thireau J; Fares N
Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):230-242. PubMed ID: 30463691
[TBL] [Abstract][Full Text] [Related]
5. Loss of Protein Phosphatase 1 Regulatory Subunit PPP1R3A Promotes Atrial Fibrillation.
Alsina KM; Hulsurkar M; Brandenburg S; Kownatzki-Danger D; Lenz C; Urlaub H; Abu-Taha I; Kamler M; Chiang DY; Lahiri SK; Reynolds JO; Quick AP; Scott L; Word TA; Gelves MD; Heck AJR; Li N; Dobrev D; Lehnart SE; Wehrens XHT
Circulation; 2019 Aug; 140(8):681-693. PubMed ID: 31185731
[TBL] [Abstract][Full Text] [Related]
6. Myeloid-Derived Growth Factor Protects Against Pressure Overload-Induced Heart Failure by Preserving Sarco/Endoplasmic Reticulum Ca
Korf-Klingebiel M; Reboll MR; Polten F; Weber N; Jäckle F; Wu X; Kallikourdis M; Kunderfranco P; Condorelli G; Giannitsis E; Kustikova OS; Schambach A; Pich A; Widder JD; Bauersachs J; van den Heuvel J; Kraft T; Wang Y; Wollert KC
Circulation; 2021 Oct; 144(15):1227-1240. PubMed ID: 34372689
[TBL] [Abstract][Full Text] [Related]
7. A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia.
Liu GS; Morales A; Vafiadaki E; Lam CK; Cai WF; Haghighi K; Adly G; Hershberger RE; Kranias EG
Cardiovasc Res; 2015 Jul; 107(1):164-74. PubMed ID: 25852082
[TBL] [Abstract][Full Text] [Related]
8. Reduced sarcoplasmic reticulum Ca2+ -ATPase activity and dephosphorylated phospholamban contribute to contractile dysfunction in human hibernating myocardium.
Nef HM; Möllmann H; Skwara W; Bölck B; Schwinger RH; Hamm Ch; Kostin S; Schaper J; Elsässer A
Mol Cell Biochem; 2006 Jan; 282(1-2):53-63. PubMed ID: 16317512
[TBL] [Abstract][Full Text] [Related]
9. Defects in ryanodine receptor function are associated with systolic dysfunction in rats subjected to volume overload.
Juric D; Yao X; Thandapilly S; Louis X; Cantor E; Chaze B; Wojciechowski P; Vasanji Z; Yang T; Wigle J; Netticadan T
Exp Physiol; 2010 Aug; 95(8):869-79. PubMed ID: 20472646
[TBL] [Abstract][Full Text] [Related]
10. Ablation of phospholamban rescues reperfusion arrhythmias but exacerbates myocardium infarction in hearts with Ca2+/calmodulin kinase II constitutive phosphorylation of ryanodine receptors.
Valverde CA; Mazzocchi G; Di Carlo MN; Ciocci Pardo A; Salas N; Ragone MI; Felice JI; Cely-Ortiz A; Consolini AE; Portiansky E; Mosca S; Kranias EG; Wehrens XHT; Mattiazzi A
Cardiovasc Res; 2019 Mar; 115(3):556-569. PubMed ID: 30169578
[TBL] [Abstract][Full Text] [Related]
11. Enhanced calcium mobilization in rat ventricular myocytes during the onset of pressure overload-induced hypertrophy.
Carvalho BM; Bassani RA; Franchini KG; Bassani JW
Am J Physiol Heart Circ Physiol; 2006 Oct; 291(4):H1803-13. PubMed ID: 16648178
[TBL] [Abstract][Full Text] [Related]
12. Loss of AKAP150 promotes pathological remodelling and heart failure propensity by disrupting calcium cycling and contractile reserve.
Li L; Li J; Drum BM; Chen Y; Yin H; Guo X; Luckey SW; Gilbert ML; McKnight GS; Scott JD; Santana LF; Liu Q
Cardiovasc Res; 2017 Feb; 113(2):147-159. PubMed ID: 27856611
[TBL] [Abstract][Full Text] [Related]
13. Targeted ablation of the histidine-rich Ca(2+)-binding protein (HRC) gene is associated with abnormal SR Ca(2+)-cycling and severe pathology under pressure-overload stress.
Park CS; Chen S; Lee H; Cha H; Oh JG; Hong S; Han P; Ginsburg KS; Jin S; Park I; Singh VP; Wang HS; Franzini-Armstrong C; Park WJ; Bers DM; Kranias EG; Cho C; Kim DH
Basic Res Cardiol; 2013 May; 108(3):344. PubMed ID: 23553082
[TBL] [Abstract][Full Text] [Related]
14. Reduced myocardial sarcoplasmic reticulum Ca(2+)-ATPase protein expression in compensated primary and secondary human cardiac hypertrophy.
Schotten U; Koenigs B; Rueppel M; Schoendube F; Boknik P; Schmitz W; Hanrath P
J Mol Cell Cardiol; 1999 Aug; 31(8):1483-94. PubMed ID: 10423346
[TBL] [Abstract][Full Text] [Related]
15. Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation.
Funk F; Kronenbitter A; Hackert K; Oebbeke M; Klebe G; Barth M; Koch D; Schmitt JP
Cardiovasc Res; 2023 Jul; 119(7):1568-1582. PubMed ID: 36869774
[TBL] [Abstract][Full Text] [Related]
16. Orai1 Channel Inhibition Preserves Left Ventricular Systolic Function and Normal Ca
Bartoli F; Bailey MA; Rode B; Mateo P; Antigny F; Bedouet K; Gerbaud P; Gosain R; Plante J; Norman K; Gomez S; Lefebvre F; Rucker-Martin C; Ainscough JFX; Kearney MT; Bruns AF; Shi J; Appleby HL; Young RS; Shawer HM; Debant M; Gomez AM; Beech DJ; Foster R; Benitah JP; Sabourin J
Circulation; 2020 Jan; 141(3):199-216. PubMed ID: 31906693
[TBL] [Abstract][Full Text] [Related]
17. Sarcoplasmic reticulum gene expression in pressure overload-induced cardiac hypertrophy in rabbit.
Matsui H; MacLennan DH; Alpert NR; Periasamy M
Am J Physiol; 1995 Jan; 268(1 Pt 1):C252-8. PubMed ID: 7840154
[TBL] [Abstract][Full Text] [Related]
18. Accelerated development of pressure overload-induced cardiac hypertrophy and dysfunction in an RyR2-R176Q knockin mouse model.
van Oort RJ; Respress JL; Li N; Reynolds C; De Almeida AC; Skapura DG; De Windt LJ; Wehrens XH
Hypertension; 2010 Apr; 55(4):932-8. PubMed ID: 20157052
[TBL] [Abstract][Full Text] [Related]
19. Activation of CaMKIIδA promotes Ca
Gui L; Guo X; Zhang Z; Xu H; Ji YW; Wang RJ; Zhu JH; Chen QH
Acta Pharmacol Sin; 2018 Oct; 39(10):1604-1612. PubMed ID: 29900930
[TBL] [Abstract][Full Text] [Related]
20. Trimetazidine protects cardiomyocytes against hypoxia-induced injury through ameliorates calcium homeostasis.
Wei J; Xu H; Shi L; Tong J; Zhang J
Chem Biol Interact; 2015 Jul; 236():47-56. PubMed ID: 25937560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
